nach oben

Erschienen in:

02.11.2018 | Original Article

Photoselective vaporization has comparative efficacy and safety among high-risk benign prostate hyperplasia patients on or off systematic anticoagulation: a meta-analysis

verfasst von: Xiaonan Zheng, Yuxuan Qiu, Shi Qiu, Liansha Tang, Kailei Nong, Xin Han, Min Li, Liuliu Quan, Lu Yang, Qiang Wei

Erschienen in: World Journal of Urology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The necessity to cease anticoagulation before photoselective vaporization (PVP) surgery remains nonconsensual. We aimed at assessing the efficacy and safety of PVP among high-risk benign prostate hyperplasia (BPH) patients on or off anticoagulation.

Methods

We systematically searched Pubmed, Embase, and Cochrane Library Central Register of Controlled Trials (CENTRAL). 2299 patients from 11 studies were eventually included. Newcastle–Ottawa Scale (NOS) was employed to assess the quality and risk of bias of each study. All statistical analyses were conducted with Review Manager v.5.3 software.

Results

Ten parameters (operation time, laser time, blood transfusion, urethral stricture, urinary tract infection, reoperation, dysuria, capsule perforation, catheterization time, and re-catheterization) from patients on or off anticoagulant therapy were collected. The patients without anticoagulants performed better at catheterization time [MD − 0.54, 95% CI (− 0.82, − 0.26), P = 0.96, I² = 0] with a reduction of 0.54 day than those on anticoagulants. Significant statistical difference was not observed from other parameters. Subgroup analysis, grouped by the power output of PVP systems (80 W, 120 W and 180 W), consistently showed no statistical significant difference except at catheterization time in the 180-W PVP subgroup.

Conclusion

PVP, a safe and effective option for high-risk BPH patients, work comparably regardless of anticoagulant therapy, despite non-anticoagulant patients have shorter catheterization time. It is implied that the use of anticoagulants might be unnecessary to stop for high-risk BPH patients undergoing PVP for the sake of safety, which certainly requires further investigations to confirm.

Nur mit Berechtigung zugänglich

Parsons JK (2010) Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep 5(4):212–218. https://doi.org/10.1007/s11884-010-0067-2 CrossRefPubMedPubMedCentral

Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic diseases in America project: benign prostatic hyperplasia. J Urol 173(4):1256–1261. https://doi.org/10.1097/01.ju.0000155709.37840.fe CrossRefPubMed

Knapp GL, Chalasani V, Woo HH (2017) Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180-W Greenlight lithium triborate laser. BJU Int 119(Suppl 5):33–38. https://doi.org/10.1111/bju.13822 CrossRefPubMed

Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO, Gravas S (2015) EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 67(6):1099–1109. https://doi.org/10.1016/j.eururo.2014.12.038 CrossRefPubMed

Bachmann A, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyere F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitan C, Knispel H, Thomas JA (2014) 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial—the GOLIATH study. Eur Urol 65(5):931–942. https://doi.org/10.1016/j.eururo.2013.10.040 CrossRefPubMed

Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T (2005) High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173(1):158–160. https://doi.org/10.1097/01.ju.0000146631.14200.d4 CrossRefPubMed

Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384–397. https://doi.org/10.1016/j.eururo.2010.06.005 CrossRefPubMed

Thangasamy IA, Chalasani V, Bachmann A, Woo HH (2012) Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 62(2):315–323. https://doi.org/10.1016/j.eururo.2012.04.051 CrossRefPubMed

Ding H, Du W, Lu ZP, Zhai ZX, Wang HZ, Wang ZP (2012) Photoselective green-light laser vaporisation vs. TURP for BPH: meta-analysis. Asian J Androl 14 (5):720–725. https://doi.org/10.1038/aja.2012.56

10.

Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE (2011) Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol 186(3):977–981. https://doi.org/10.1016/j.juro.2011.04.068 CrossRefPubMed

11.

Sandhu JS, Gotto GT, Herran LA, Scardino PT, Eastham JA, Rabbani F (2011) Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy. J Urol 185(6):2148–2152. https://doi.org/10.1016/j.juro.2011.02.003 CrossRefPubMed

12.

EAU Guidelines. Edn. presented at the EAU Annual Congress Copenhagen 2018 (2018). Eur Urol

13.

Chen CH, Lin SE, Chiang PH (2013) Outcome of GreenLight HPS laser therapy in surgically high-risk patients. Lasers Med Sci 28(5):1297–1303. https://doi.org/10.1007/s10103-012-1234-9 CrossRefPubMed

14.

Chen LJ, Mai HX, Zhao L, Qu N, Wang YL, Huang C, Li XC, Dong JK, Tang F, Chen B (2013) Experience of treating high risk prostate hyperplasia patients with a HPS120 laser. BMC Urol 13:64. https://doi.org/10.1186/1471-2490-13-64 CrossRefPubMedPubMedCentral

15.

Choi YS, Bae WJ, Kim SJ, Kim KS, Cho HJ, Hong SH, Lee JY, Hwang TK, Kim SW (2013) Efficacy and safety of 120-W greenlight high-performance system laser photo vaporization of the prostate: 3-year results with specific considerations. Prostate Int 1(4):169–176. https://doi.org/10.12954/PI.13030 CrossRefPubMedPubMedCentral

16.

Piotrowicz G, Syrylo T, Jedynak R, Zielinski H (2017) Efficacy and safety of photoselective vaporization of the prostate with 120 W 532 nm laser in patients with benign prostatic hyperplasia on anticoagulation or antiplatelet therapy: observations on long-term outcomes. Photomed Laser Surg. https://doi.org/10.1089/pho.2017.4367

17.

Karatas OF, Alkan E, Horasanli K, Luleci H, Sarica K (2010) Photoselective vaporization of the prostate in men with a history of chronic oral anti-coagulation. Int Braz J Urol 36(2):190–197CrossRefPubMed

18.

Lee DJ, Rieken M, Halpern J, Zhao F, Pueschel H, Chughtai B, Kaplan SA, Lee RK, Bachmann A, Te AE (2016) Laser vaporization of the prostate with the 180-W XPS-greenlight laser in patients with ongoing platelet aggregation inhibition and oral anticoagulation. Urology 91:167–173. https://doi.org/10.1016/j.urology.2016.01.021 CrossRefPubMed

19.

Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51 (4):1031–1038. https://doi.org/10.1016/j.eururo.2006.08.006 (discussion 1038–1041)

20.

Shao IH, Hou CP, Chen SM, Chen CL, Lin YH, Chang PL, Tsui KH (2013) The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia. Clin Interv Aging 8:265–269. https://doi.org/10.2147/cia.s41270 CrossRefPubMedPubMedCentral

21.

Sohn JH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, Hwang TK, Kim SW (2011) Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol 52(3):178–183. https://doi.org/10.4111/kju.2011.52.3.178 CrossRefPubMedPubMedCentral

22.

Woo H, Reich O, Bachmann A, Choi B, Collins E, Rosette JDL, Sancha FG, Muir G, Tabatabaei S (2008) Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (≥ 80 ml). Eur Urol Suppl 7(4):378–383CrossRef

23.

Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed

24.

Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5(1):13. https://doi.org/10.1186/1471-2288-5-13 CrossRefPubMedPubMedCentral

25.

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560CrossRefPubMedPubMedCentral

26.

Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA (2011) Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer? The American Journal Of Gastroenterology 106:1911. https://doi.org/10.1038/ajg.2011.301. https://www.nature.com/articles/ajg2011301#supplementary-information

27.

Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Borges FD, Rashid P (2015) Three year results of the prostatic urethral L.I.F.T. study. Can J Urol 22(3):7772–7782

28.

Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP Jr, Trainer A, Arther A, Badlani G, Plante M, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C (2018) WATER: a double-blind, randomized, controlled trial of aquablation((R)) vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol 199(5):1252–1261. https://doi.org/10.1016/j.juro.2017.12.065 CrossRefPubMed

29.

Bagla S, Martin CP, van Breda A, Sheridan MJ, Sterling KM, Papadouris D, Rholl KS, Smirniotopoulos JB, van Breda A (2014) Early results from a United States trial of prostatic artery embolization in the treatment of benign prostatic hyperplasia. J Vasc Intervent Radiol JVIR 25(1):47–52. https://doi.org/10.1016/j.jvir.2013.09.010 CrossRef

30.

Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE (2005) Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 19(10):1196–1198. https://doi.org/10.1089/end.2005.19.1196 CrossRefPubMed

31.

Malloy TR, Sandhu JS, Smith AL, Reddy B, Harryhill JF, Kaplan SA, Te AE 1562: photoselective vaporization of the prostate (PVP) in anticoagulated patients: a multicenter retrospective evaluation of feasibility. J Urol 173(4):423. https://doi.org/10.1016/s0022-5347(18)35696-9

32.

Parr NJ, Loh CS, Desmond AD (1989) Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol 64(6):623–625CrossRefPubMed

33.

Chakravarti A, MacDermott S (1998) Transurethral resection of the prostate in the anticoagulated patient. Br J Urol 81(4):520–522CrossRefPubMed

Titel: Photoselective vaporization has comparative efficacy and safety among high-risk benign prostate hyperplasia patients on or off systematic anticoagulation: a meta-analysis
verfasst von: Xiaonan Zheng
Yuxuan Qiu
Shi Qiu
Liansha Tang
Kailei Nong
Xin Han
Min Li
Liuliu Quan
Lu Yang
Qiang Wei
Publikationsdatum: 02.11.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 7/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2530-1

Neu im Fachgebiet Urologie

22.04.2024 | Prostatakarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Photoselective vaporization has comparative efficacy and safety among high-risk benign prostate hyperplasia patients on or off systematic anticoagulation: a meta-analysis

Abstract

Purpose

Methods

Results

Conclusion

Neu im Fachgebiet Urologie

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Urologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2019

Prediction of biochemical failure using prostate-specific antigen half-life in patients with adverse pathologic features after radical prostatectomy

Supracostal access tubeless percutaneous nephrolithotomy: minimizing complications

Prevalence and surgical management of concurrent adult acquired buried penis and urethral stricture disease

Does routine repeat imaging change management in high-grade renal trauma? Results from three level 1 trauma centers

Lower urinary tract dysfunction in chronic Chagas disease: clinical and urodynamic presentation

Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study

Neu im Fachgebiet Urologie

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Varikozelen bei Jugendlichen: Das Für und Wider der Operation

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Urologie